BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35568648)

  • 1. RHOA takes the RHOad less traveled to cancer.
    Schaefer A; Der CJ
    Trends Cancer; 2022 Aug; 8(8):655-669. PubMed ID: 35568648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
    Hodge RG; Schaefer A; Howard SV; Der CJ
    Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
    Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
    Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA.
    Chang YW; Putzer K; Ren L; Kaboord B; Chance TW; Qoronfleh MW; Jakobi R
    J Cell Biochem; 2005 Oct; 96(2):314-29. PubMed ID: 16088958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
    Zhu Y; Casey PJ; Kumar AP; Pervaiz S
    Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of type I phosphatidylinositol 4-phosphate 5-kinase isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42.
    Weernink PA; Meletiadis K; Hommeltenberg S; Hinz M; Ishihara H; Schmidt M; Jakobs KH
    J Biol Chem; 2004 Feb; 279(9):7840-9. PubMed ID: 14681219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho GTPases in cancer: friend or foe?
    Svensmark JH; Brakebusch C
    Oncogene; 2019 Dec; 38(50):7447-7456. PubMed ID: 31427738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes.
    Teramoto H; Malek RL; Behbahani B; Castellone MD; Lee NH; Gutkind JS
    Oncogene; 2003 May; 22(17):2689-97. PubMed ID: 12730683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optogenetic control of small GTPases reveals RhoA mediates intracellular calcium signaling.
    Inaba H; Miao Q; Nakata T
    J Biol Chem; 2021; 296():100290. PubMed ID: 33453281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors.
    Rihet S; Vielh P; Camonis J; Goud B; Chevillard S; de Gunzburg J
    J Cancer Res Clin Oncol; 2001 Dec; 127(12):733-8. PubMed ID: 11768613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells.
    Wojciak-Stothard B; Tsang LY; Haworth SG
    Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L749-60. PubMed ID: 15591411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rho family of small GTPases is involved in epithelial cystogenesis and tubulogenesis.
    Rogers KK; Jou TS; Guo W; Lipschutz JH
    Kidney Int; 2003 May; 63(5):1632-44. PubMed ID: 12675838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA- and RhoD-dependent regulatory switch of Galpha subunit signaling by PAR-1 receptors in cellular invasion.
    Nguyen QD; Faivre S; Bruyneel E; Rivat C; Seto M; Endo T; Mareel M; Emami S; Gespach C
    FASEB J; 2002 Apr; 16(6):565-76. PubMed ID: 11919159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters.
    Fritz G; Brachetti C; Bahlmann F; Schmidt M; Kaina B
    Br J Cancer; 2002 Sep; 87(6):635-44. PubMed ID: 12237774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
    Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras and RhoA suppress whereas RhoB enhances cytokine-induced transcription of nitric oxide synthase-2 in human normal liver AKN-1 cells and lung cancer A-549 cells.
    Delarue FL; Taylor BS; Sebti SM
    Oncogene; 2001 Oct; 20(45):6531-7. PubMed ID: 11641777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variegated RHOA mutations in human cancers.
    Kataoka K; Ogawa S
    Exp Hematol; 2016 Dec; 44(12):1123-1129. PubMed ID: 27693615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin-mediated RhoGDI phosphorylation via PKCĪ± promotes both RhoA and Rac1 signaling.
    Sabbatini ME; Williams JA
    PLoS One; 2013; 8(6):e66029. PubMed ID: 23776598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin.
    Bruewer M; Hopkins AM; Hobert ME; Nusrat A; Madara JL
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C327-35. PubMed ID: 15044152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.